Kellner Group urges AIM ImmunoTech stockholders to vote for its nominees

Ted Kellner, as the nominating stockholder and a nominee, together with his other nominees, Todd Deutsch, Robert L. Chioini and Paul W. Sweeney issued a press release in connection with their efforts to bring accountability to the entrenched, incumbent Board of Directors of AIM Immunotech (AIM). The release said in part, “It is clear that the entrenched AIM Board will say anything and do anything, no matter the terrible consequences to stockholders, in their self-interested effort to keep their board seats at all costs. These are the relevant facts: Each of the Kellner Group Nominees will bring desperately needed skills, resources, experience and credibility to AIM’s Board – each of them is an accomplished and respected business person in their field and none of them has any criminal history whatsoever. There are no other AIM stockholders or other third parties involved in the Kellner Group’s activities, nor were there any other AIM stockholders or other third parties involved in Mr. Kellner’s nominations and solicitation for AIM’s 2023 annual meeting of stockholders. The AIM Board’s tired and pathetic attempt to connect the Kellner Group to Mr. Tudor and Mr. Xirinachs – who have no role whatsoever with the Kellner Group – is just another misleading distraction from their own fiduciary duty breaches, the plummeting stock price that continues to reach new lows and the desperate financial condition of AIM under their watch.”